Octagon Capital Advisors Lp Portfolio Stock Holdings

According to the SEC 13F filed on August 14, 2026, Octagon Capital Advisors Lp disclosed 18 stock positions valued at approximately $1.09B as of quarter-end June 30, 2026. The largest holdings include DIANTHUS THERAPEUTICS INC, ABIVAX SA, and COGENT BIOSCIENCES INC.

Report Period
June 30, 2026
No. of Stocks
18
Portfolio Value
$1.09B
Holdings by Sector
Octagon Capital Advisors Lp Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
DIANTHUS THERAPEUTICS INCDNTHHealthcare16.48%1,841,667-105,000-5.39%$179,525,699
ABIVAX SAABVXHealthcare12.15%993,000+316,000+46.68%$132,327,180
COGENT BIOSCIENCES INCCOGTHealthcare8.35%2,350,000--$90,945,000
ALUMIS INCALMSHealthcare7.31%2,830,700--$79,655,898
ARRIVENT BIOPHARMA INCAVBPHealthcare6.28%1,971,054--$68,474,416
TAYSHA GENE THERAPIES INCTSHAHealthcare6.06%9,693,244+833,333+9.41%$66,010,992
MIRUM PHARMACEUTICALS INCMIRMHealthcare3.64%338,900--$39,675,023
KYMERA THERAPEUTICS INCKYMRHealthcare3.26%310,000-115,000-27.06%$35,547,700
XENON PHARMACEUTICALS INCXENEHealthcare2.71%490,000--$29,576,400
OCULAR THERAPEUTIX INCOCULHealthcare1.87%2,075,000-1,091,600-34.47%$20,376,500
DISC MEDICINE INCIRONHealthcare1.81%270,000--$19,747,800
SUMMIT THERAPEUTICS INCSMMTHealthcare1.67%1,250,000+1,250,000+100.00%$18,212,500
PHARVARIS N VPHVSOther1.45%456,721+291,721+176.80%$15,793,412
PRECISION BIOSCIENCES INCDTILHealthcare0.97%1,350,000-886,732-39.64%$10,611,000
GYRE THERAPEUTICS INCGYREHealthcare0.58%954,416+954,416+100.00%$6,289,601
TREVI THERAPEUTICS INCTRVIHealthcare0.54%315,000-1,170,000-78.79%$5,874,750
CONTEXT THERAPEUTICS INCCNTXHealthcare0.16%3,050,000-2,200,000-41.90%$1,689,395
GOSSAMER BIO INCGOSSHealthcare0.12%7,750,000--$1,275,650
Showing 18 of 18 holdings in the latest reporting period.
Octagon Capital Advisors Lp Portfolio Stock Holdings | InsiderSet